Skip to main content

Table 2 Treatments and dosimetric features

From: Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis

  CK hFSRT nFSRT p-value
GTV [ml], mean ± sd 10.1 ± 11.9 25.1 ± 31.2 < .001
Single dose [Gy], mean ± sd 5.2 ± 0.9 1.8 ± 0.1 < .001
Single dose [Gy], median (range) 5.0 (2.67–8) 1.8 (1.8–2.8)  
Total dose [Gy], mean ± sd 24.6 ± 4.9 56.9 ± 4.2 < .001
Total dose [Gy], median (range) 25 (15–61) 59.4 (32.4–63)  
Prescription isodose [%], mean ± sd 75.6 ± 5.3 95 ± 0 < .001
Prescription isodose [%], median (range) 75.0 (60.0–100.0) 95 (95–95)  
EQD2 [Gy], mean ± sd 44.1 ± 8.1 54. 2 ± 3.8 < .001
EQD2 [Gy], median (range) 43.8 (26.3–100.0) 56.43 (30.78–60)  
BED [Gy], mean ± sd 88.1 ± 16.3 108.5 ± 7.5 < .001
BED [Gy], median (range) 87.5 (52.5–200) 112.9 (61.6–120)